Expression of vascular endothelial growth factors-C and -D correlate with evidence of lymphangiogenesis and angiogenesis in pancreatic adenocarcinoma
Authors:
- Wen-Hua ZhaoWZWen-Hua Zhao
- Wu-Yuan ZhouWZWu-Yuan Zhou
- Wen-Sheng YuWYWen-Sheng Yu
- Jin-Ming YuJYJin-Ming Yu
- Sheng LiSLSheng Li
- 31 December 2007
- journal article
- Published by Elsevier in Cancer Detection Prevention
- Vol. 31 (6) , 436-442
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- One Thousand Consecutive PancreaticoduodenectomiesAnnals of Surgery, 2006
- Impact of Vascular Endothelial Growth Factor-C and -D Expression in Human Pancreatic CancerClinical Cancer Research, 2004
- Pancreatic cancerThe Lancet, 2004
- Expression of Vascular Endothelial Growth Factor C and D (VEGF-C and -D) is an Important Risk Factor for Lymphatic Metastasis in Undifferentiated Early Gastric CarcinomaJapanese Journal of Clinical Oncology, 2003
- Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 SignalingJNCI: Journal of the National Cancer Institute, 2002
- Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3The EMBO Journal, 2001
- VEGF-D promotes the metastatic spread of tumor cells via the lymphaticsNature Medicine, 2001
- Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasisNature Medicine, 2001
- Vascular-specific growth factors and blood vessel formationNature, 2000
- Standards for Pancreatic Resection in the 1990sArchives of Surgery, 1995